In 2020, approximately 604 127 patients were newly diagnosed with cervical cancer and
341 831 died of the disease worldwide. Unfortunately, 85–90% of new cases and deaths …

Background: Each year 604,127 new cases of cervical cancer (CC) are diagnosed, and
341,831 individuals die from the disease. It is the fourth most common cancer among …

Background Shifting from cytology to human papillomavirus (HPV)-based cervical cancer
screening will initially increase colposcopy referrals. The anticipated impact on health …

El cáncer de cérvix en el 99% de los casos, es causado por el Virus del Papiloma Humano
(VPH) de alto riesgo, su prevalencia es elevada en países de bajos ingresos debido a la …

Background Danish women—who were HPV-vaccinated as girls—are now reaching an age
where they are invited to cervical cancer screening. Because of their expected lower cervical …

Cervical cancer is the fourth most common malignancy in women worldwide. The
identification of human papillomavirus (HPV) as the main etiologic cause of cervical cancer …

Background With HPV screening the specificity of screening positives has decreased, even
with a cytological triage test. Increases in colposcopies and detection of benign or low-grade …

El cáncer de cérvix en el 99% de los casos, es causado por el Virus del Papiloma Humano
(VPH) de alto riesgo, su prevalencia es elevada en países de bajos ingresos debido a la …

Cytology-based cervical cancer screening achieved undisputable success in reducing the
incidence and mortality of cervical cancer in many countries of the world, especially high …

Objective The aim of this cost-effectiveness analysis is to, from a health economics
perspective, compare the current Swedish national cervical screening program for women …